Serum Half-life of Pituitary Gonadotropins is Decreased by Sulfonation and Increased by Sialylation in Women
Overview
Affiliations
Context: The gonadotropins are secreted from the human pituitary as spectra of isoforms with different degrees of sulfonation and sialylation of the oligosaccharides, modifications suspected to determine their half-lives in the circulation.
Objectives: Our objectives were to determine the isoform composition of the serum gonadotropins during GnRH receptor blockade, and to estimate the half-lives in circulation of isoforms with 0-1-2-3 sulfonated N-acetylgalactosamine (SO(3)-GalNAc) residues.
Design/participants: Serum samples were collected in seven healthy women before and up to 20 h after administration of the NAL-GLU GnRH antagonist.
Main Outcome Measures: The number of sialic acid and SO(3)-GalNAc residues per LH and FSH molecule and the distribution of molecules with 0-1-2-3 sulfonated residues were measured. The half-lives were estimated by monoexponential decay.
Results: More sialylated and less sulfonated gonadotropin isoforms remain longer in circulation during GnRH receptor blockade. LH isoforms with two and three sulfonated residues per molecule had shorter half-lives compared with those with zero and one (109 and 80 vs. 196 and 188 min; P < 0.01). FSH isoforms with one and two sulfonated residues had shorter half-lives than those with zero (485 and 358 vs. 988 min; P < 0.01).
Conclusions: The decline in LH and FSH during GnRH receptor blockade is associated with a decrease in sulfonated and increase in sialylated residues. The rapid disappearance of LH isoforms with two and three SO(3)-GalNAc residues suggests their removal by hepatic SO(3)-GalNAc-receptors similar to those in rodents. Episodical secretion of spectra of isoforms with different half-lives is expected to lead to continuous changes in gonadotropin isoform compositions in blood.
Iles R, Iles J, Lacey J, Gardiner A, Zmuidinaite R Diagnostics (Basel). 2022; 12(10).
PMID: 36292212 PMC: 9601263. DOI: 10.3390/diagnostics12102521.
Wide L, Eriksson K, Sluss P, Hall J J Clin Endocrinol Metab. 2022; 107(10):e4058-e4062.
PMID: 35914268 PMC: 9731043. DOI: 10.1210/clinem/dgac434.
Sinegubova M, Vorobiev I, Klishin A, Eremin D, Orlova N, Orlova N Pharmaceutics. 2022; 14(1).
PMID: 35056992 PMC: 8781808. DOI: 10.3390/pharmaceutics14010096.
Low- and Fully N-Glycosylated Gonadotropins Circulating in Women With Polycystic Ovary Syndrome.
Wide L, Naessen T, Sundstrom-Poromaa I, Eriksson K J Endocr Soc. 2021; 5(7):bvab080.
PMID: 34159285 PMC: 8212672. DOI: 10.1210/jendso/bvab080.
Reduced FSH and LH action: implications for medically assisted reproduction.
Bosch E, Alviggi C, Lispi M, Conforti A, Hanyaloglu A, Chuderland D Hum Reprod. 2021; 36(6):1469-1480.
PMID: 33792685 PMC: 8129594. DOI: 10.1093/humrep/deab065.